Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05077826 · ClinicalTrials.gov registry record · NA
Enhancing Memory in Mild Cognitive Impairment and Early Stage Alzheimer's Disease
A NA study, sponsored by The Mind Research Network.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
NCT05077826: Completed NA study, sponsored by The Mind Research Network.
NCT05077826 is a NA study that has completed, run by The Mind Research Network. The registered enrollment target is 98 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05077826, a NA study, has completed, sponsored by The Mind Research Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
Study Summary
The investigators have developed a low-risk transcranial Electrical Stimulation (tES) treatment that has improved learning and performance in young adults up to nearly 4 times when compared with a sham control. This randomized pilot trial will determine if this same tES protocol improves memory in older adults (50-90 years old) who are healthy, and separately in older adults with mild cognitive impairment (MCI) or early stage Alzheimer's disease (AD). TES will be applied to the right temple and left arm for up to 40 minutes. MRI images, along with other measures, may be obtained before and after tES. If effective, this intervention may help to improve the quality of life for AD patients and their families.
Primary Outcome
Performance accuracy on a complex visual learning and categorization task after full-current tES in comparison to partial-current tES.
Interventions
- DEVICE North Coast Medical Activadose II
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2021-10-07 |
| Est. Completion | 2023-04-30 |
| Phase | NA |
What the finished NCT05077826 record still lists
NCT05077826 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which North Coast Medical Activadose II is the first listed.
NCT05077826 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05077826 about?
NCT05077826 is a clinical study titled "Enhancing Memory in Mild Cognitive Impairment and Early Stage Alzheimer's Disease". The investigators have developed a low-risk transcranial Electrical Stimulation (tES) treatment that has improved learning and performance in young adults up to nearly 4 times when compared with a sham control. This randomized pilot trial will determine if this same tES protocol improves memory in o...
What is the current status of trial NCT05077826?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2021-10-07. Estimated completion is 2023-04-30.
What interventions are being tested in trial NCT05077826?
The interventions under investigation include: North Coast Medical Activadose II (DEVICE).
Who is sponsoring clinical trial NCT05077826?
This trial is sponsored by The Mind Research Network, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05077826's enrollment target sits among peer trials
98 922nd of 2000 higher than 1,078 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI